Quick Comparison
| Phenibut | Vitamin D3 | |
|---|---|---|
| Half-Life | 5-6 hours | 15-25 days |
| Typical Dosage | Standard: 250-1000 mg on an empty stomach, no more than 1-2 times per week. NEVER use daily — tolerance and dependence develop within 3-5 days of consecutive use. Onset: 2-4 hours (slow). Do not exceed 2000 mg per occasion. | Standard: 2000-5000 IU daily. Optimal blood level: 40-60 ng/mL (100-150 nmol/L). Most adults need 4000-5000 IU to reach optimal levels. Take with fat for absorption. Get blood levels tested before supplementing — both deficiency and excess are harmful. |
| Administration | Oral (powder, capsules). Take on an empty stomach — food significantly reduces absorption. Slow onset (2-4 hours). | Oral (softgels, drops, tablets). D3 (cholecalciferol) preferred over D2 (ergocalciferol). Take with a fat-containing meal. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Phenibut
Phenibut is a structural analog of GABA with a phenyl ring that confers lipophilicity and allows blood-brain barrier penetration (unlike GABA itself). It acts as a GABA-B receptor agonist, binding to the GABAB1/GABAB2 heterodimer and activating Gi/o-coupled signaling (similar to baclofen), producing anxiolytic, muscle relaxant, and sedative effects through inhibition of adenylyl cyclase and modulation of potassium and calcium channels. Phenibut also blocks the alpha-2-delta-1 and alpha-2-delta-2 subunits of voltage-gated calcium channels, reducing presynaptic calcium influx and neurotransmitter release (similar to gabapentin/pregabalin). The dual mechanism—GABA-B agonism dampening inhibitory interneurons and calcium channel blockade reducing excitatory transmission—produces potent anti-anxiety and sleep-promoting effects. Rapid tolerance develops due to receptor downregulation.
Vitamin D3
Vitamin D (1,25-dihydroxyvitamin D3) crosses the blood-brain barrier and binds to vitamin D receptors (VDR), a nuclear receptor expressed on neurons, astrocytes, microglia, and oligodendrocytes. VDR heterodimerizes with RXR and binds vitamin D response elements (VDREs) to regulate transcription. It upregulates neurotrophic factors: GDNF (glial cell line-derived), NGF, NT-3 via CREB and other transcription factors. Vitamin D promotes serotonin synthesis by upregulating tryptophan hydroxylase 2 (TPH2) and dopamine synthesis via tyrosine hydroxylase. It reduces neuroinflammation by suppressing microglial IL-1beta, TNF-alpha, and iNOS, and supports calcium homeostasis via regulation of L-type voltage-gated calcium channels and calbindin-D28k. Vitamin D regulates over 200 genes including those for neuroprotection, synaptic plasticity, and myelination.
Risks & Safety
Phenibut
Common
Drowsiness, dizziness, nausea, tolerance with repeated use.
Serious
Physical dependence develops rapidly with daily use. Withdrawal can be severe and dangerous (anxiety, insomnia, psychosis, seizures). Respiratory depression when combined with alcohol or other CNS depressants.
Rare
Hallucinations, severe rebound anxiety, suicidal ideation during withdrawal.
Vitamin D3
Common
Generally very safe at standard doses.
Serious
Toxicity at very high doses (>10,000 IU daily for months) — causes hypercalcemia (nausea, kidney stones, cardiac arrhythmia).
Rare
Headache, metallic taste, nausea.
Full Profiles
Phenibut →
A GABA-B agonist and alpha-2-delta voltage-gated calcium channel blocker developed in Russia for anxiety, insomnia, and PTSD. It crosses the blood-brain barrier (unlike GABA supplements) and produces potent anxiolytic and social confidence effects. However, it carries significant addiction and withdrawal risks — tolerance develops within days of daily use, and withdrawal can be severe.
Vitamin D3 →
Technically a hormone, not a vitamin. Vitamin D3 (cholecalciferol) receptors are found throughout the brain, particularly in the hippocampus and prefrontal cortex. Deficiency — affecting an estimated 40-75% of adults worldwide — is associated with cognitive impairment, depression, and increased Alzheimer's risk. Supplementation is one of the most impactful interventions for people with low levels.